Citations

Clear

1053 citation(s) found for "Andre, F".

The Dynamic Architectural and Epigenetic Nuclear Landscape: Developing the Genomic Almanac of Biology and Disease
Zaidi, Sayyed K. , Wu, Hai , Grandy, Rodrigo A. , Montecino, Martı́n , Wijnen, André J. van , Lian, Jane B. , Stein, Gary S., Stein, Janet L. , Tai, Phillip W.L. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | November 15, 2013 | Volume: 229 | Issue: 6 | Pages: 711-727

10.1002/jcp.24508 | PMID 24242872 Get It

Shear wave dispersion ultrasound vibrometry of gel dosimetry phantoms.
Vieira, Sílvio Leão , Urban, Matthew W. , Baggio, André L., Carneiro, Antônio Adilton Oliveira , Fatemi, Mostafa , Urban, Matthew W

Mayo Clinic

The Journal of the Acoustical Society of America | October 28, 2013 | Volume: 125 | Issue: 4_Supplement | Pages: 2553-2553

10.1121/1.4783660 Get It

Shear wave dispersion ultrasound vibrometry (SDUV) has been introduced to use the dispersive nature of shear wave speed to locally estimate the material properties or tissue. Shear waves were created using a mechanical shaker and pulsed radiation force. Using the information from the phase one can estimate the shear velocity. A theoretical Voigt model allows us to find, at different frequencies (100–400 Hz), the viscosity and shear elasticity of the polymer gel dosimeter. The aim of this work was to perform the SDUV and mechanical vibrometry techniques to study the viscoelastic properties of absorbed dose phantoms. The experiments were performed using five phantoms of different absorbed doses varying 10 up to 50 Gy, while a nonirradiated phantom was kept as a control. The SDUV technique was performed using a pulsed radiation force to vibrate the gel provide by a confocal transducer with a focal depth of 70 mm, nominal frequency of 3 MHz. For the mechanical vibrometry and SDUV experiments, shear wave motion measurements were made with a commercial ultrasound machine with a research using a 10 MHz linear array transducer. The quantitative elasticity and viscosity results for these two experiments were compared.
Are Meningeal Hemangiopericytoma and Mesenchymal Chondrosarcoma the Same?
Fritchie, Karen , Jin, Long , Ruano, Ana Belén García , Oliveira, André M. , Fritchie, Karen J. , Rubin, Brian P.

Mayo Clinic

American Journal of Clinical Pathology | October 11, 2013 | Volume: 140 | Issue: 5 | Pages: 670-674

10.1309/ajcpgungp52zsdns | PMID 24124145 Get It

A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I
Worcester, Elaine M. , Evan, Andrew P., Coe, Fredric L. , Lingeman, James E., Krambeck, Amy E. , Sommers, Andre, Phillips, Carrie L. , Milliner, Dawn S.

Mayo Clinic

American Journal of Physiology-Renal Physiology | October 3, 2013 | Volume: 305 | Issue: 11 | Pages: F1574-F1584

10.1152/ajprenal.00382.2013 | PMID 24089413 Get It

The sequence of events by which primary hyperoxaluria type 1 (PH1) causes renal failure is unclear. We hypothesize that proximal tubule (PT) is vulnerable because oxalate secretion raises calcium oxalate (CaOx) supersaturation (SS) there, leading to crystal formation and cellular injury. We studied cortical and papillary biopsies from two PH1 patients with preserved renal function, and seven native kidneys removed from four patients at the time of transplant, after short-term ( 2 ) or longer term ( 2 ) dialysis. In these patients, and another five PH1 patients without renal failure, we calculated oxalate secretion, and estimated PT CaOx SS. Plasma oxalate was elevated in all PH1 patients and inverse to creatinine clearance. Renal secretion of oxalate was present in all PH1 but rare in controls. PT CaOx SS was >1 in all nonpyridoxine-responsive PH1 before transplant and most marked in patients who developed end stage renal disease (ESRD). PT from PH1 with preserved renal function had birefringent crystals, confirming the presence of CaOx SS, but had no evidence of cortical inflammation or scarring by histopathology or hyaluronan staining. PH1 with short ESRD showed CaOx deposition and hyaluronan staining particularly at the corticomedullary junction in distal PT while cortical collecting ducts were spared. Longer ESRD showed widespread cortical CaOx, and in both groups papillary tissue had marked intratubular CaOx deposits and fibrosis. CaOx SS in PT causes CaOx crystal formation, and CaOx deposition in distal PT appears to be associated with ESRD. Minimizing PT CaOx SS may be important for preserving renal function in PH1.
Natural Cardiogenesis-Based Template Predicts Cardiogenic Potential of Induced Pluripotent Stem Cell Lines
Martinez‐Fernandez, Almudena , Li, Xing , Hartjes, Katherine A., Terzic, André , Nelson, Timothy J.

Mayo Clinic

Circulation: Cardiovascular Genetics | September 15, 2013 | Volume: 6 | Issue: 5 | Pages: 462-471

10.1161/circgenetics.113.000045 | PMID 24036272 Get It

Background— Cardiac development is a complex process resulting in an integrated, multilineage tissue with developmental corruption in early embryogenesis leading to congenital heart disease. Interrogation of individual genes has provided the backbone for cardiac developmental biology, yet a comprehensive transcriptome derived from natural cardiogenesis is required to gauge innate developmental milestones. Methods and Results— Stage-specific cardiac structures were dissected from 8 distinctive mouse embryonic time points to produce genome-wide expressome analysis across cardiogenesis. With reference to this native cardiogenic expression roadmap, divergent induced pluripotent stem cell–derived cardiac expression profiles were mapped from procardiogenic 3-factor (SOX2, OCT4, KLF4) and less-cardiogenic 4-factor (plus c-MYC) reprogrammed cells. Expression of cardiac-related genes from 3-factor–induced pluripotent stem cell differentiated in vitro at days 5 and 11 and recapitulated expression profiles of natural embryos at days E7.5-E8.5 and E14.5-E18.5, respectively. By contrast, 4-factor–induced pluripotent stem cells demonstrated incomplete cardiogenic gene expression profiles beginning at day 5 of differentiation. Differential gene expression within the pluripotent state revealed 23 distinguishing candidate genes among pluripotent cell lines with divergent cardiogenic potentials. A confirmed panel of 12 genes, differentially expressed between high and low cardiogenic lines, was transformed into a predictive score sufficient to discriminate individual induced pluripotent stem cell lines according to relative cardiogenic potential. Conclusions— Transcriptome analysis attuned to natural embryonic cardiogenesis provides a robust platform to probe coordinated cardiac specification and maturation from bioengineered stem cell–based model systems. A panel of developmental-related genes allowed differential prognosis of cardiogenic competency, thus prioritizing cell lines according to natural blueprint to streamline functional applications.
Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database
Shi, Qian , André, Thierry , Yothers, Greg , Bot, Brian M. , Haller, Daniel G. , Twelves, Chris , Benedetti, Jacqueline, Grothey, Axel , Hamilton, Stanley R. , Cutsem, Eric Van , O’Connell, Michael J. , Sargent, Daniel J. , André, Thierry , Shi, Qian , Yothers, Greg

Mayo Clinic

Journal of Clinical Oncology | August 27, 2013 | Volume: 31 | Issue: 29 | Pages: 3656-3663

10.1200/jco.2013.49.4344 | PMID 23980089 Get It

Purpose With improved patient care, better diagnosis, and more treatment options after tumor recurrence, outcomes after fluorouracil (FU) -based treatment are expected to have improved over time in early-stage colon cancer. Data from 18,449 patients enrolled onto 21 phase III trials conducted from 1978 to 2002 were evaluated for potential differences in time to recurrence (TTR), time from recurrence to death (TRD), and overall survival (OS) with regard to FU-based adjuvant regimens. Methods Trials were predefined as old versus newer era using initial accrual before or after 1995. Outcomes were compared between patients enrolled onto old- or newer-era trials, stratified by stage. Results Within the first 3 years, recurrence rates were lower in newer- versus old-era trials for patients with stage II disease, with no differences among those with stage III disease. Both TRD and OS were significantly longer in newer-era trials overall and within each stage. The lymph node (LN) ratio (ie, number of positive nodes divided by total nodes harvested) in those with stage III disease declined over time. TTR improved slightly, with larger number of LNs examined in both stages. Conclusion Improved TRD in newer trials supports the premise that more aggressive intervention (oxaliplatin- and irinotecan-based chemotherapy and/or surgery for recurrent disease) improves OS for patients previously treated in the adjuvant setting. Lower recurrence rates with identical treatments in those with stage II disease enrolled onto newer-era trials reflect stage migration over time, calling into question historical data related to the benefit of FU-based adjuvant therapy in such patients.
Systems Approaches Evolve Clinical Pharmacology
Waldman, Scott A. , Graaf, PH van der, Terzic, André , Waldman, Scott A

Mayo Clinic

CPT: Pharmacometrics & Systems Pharmacology | August 21, 2013 | Volume: 2 | Issue: 8 | Pages: 1-2

10.1038/psp.2013.48 | PMID 23965784 Get It

CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e68; doi:10.1038/psp.2013.48; advance online publication 21 August 2013
FGFR1 Signaling Stimulates Proliferation of Human Mesenchymal Stem Cells by Inhibiting the Cyclin-Dependent Kinase Inhibitors p21Waf1 and p27Kip1
Dombrowski, Christian, Helledie, Torben, Grünert, Martin, Canning, Claire Ann, Jones, C. Michael , Hui, James Hoi Po , Nurcombe, Victor , Wijnen, André J. van , Cool, Simon M. , Ling, Ling , van Wijnen, Andre J

Mayo Clinic

Stem Cells | August 13, 2013 | Volume: 31 | Issue: 12 | Pages: 2724-2736

10.1002/stem.1514 | PMID 23939995 Get It

Abstract Signaling through fibroblast growth factor receptor one (FGFR1) is a known inducer of proliferation in both embryonic and human adult mesenchymal stem cells (hMSCs) and positively regulates maintenance of stem cell viability. Leveraging the mitogenic potential of FGF2/FGFR1 signaling in stem cells for therapeutic applications necessitates a mechanistic understanding of how this receptor stimulates cell cycle progression. Using small interfering RNA (siRNA) depletion, antibody-inhibition, and small molecule inhibition, we establish that FGFR1 activity is rate limiting for self-renewal of hMSCs. We show that FGFR1 promotes stem cell proliferation through multiple mechanisms that unite to antagonize cyclin-dependent kinase (CDK) inhibitors. FGFR1 not only stimulates c-Myc to suppress transcription of the CDK inhibitors p21Waf1 and p27Kip1, thus promoting cell cycle progression but also increases the activity of protein kinase B (AKT) and the level of S-phase kinase-associated protein 2 (Skp2), resulting in the nuclear exclusion and reduction of p21Waf1. The in vivo importance of FGFR1 signaling for the control of proliferation in mesenchymal progenitor populations is underscored by defects in ventral mesoderm formation during development upon inhibition of its signaling. Collectively, these studies demonstrate that FGFR1 signaling mediates the continuation of MSC growth and establishes a receptor target for enhancing the expansion of mesenchymal progenitors while maintaining their multilineage potential. Stem Cells 2013;31:2724–2736
Non‐invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C
Crespo, Sergio M., Bridges, Mellena D., Nakhleh, Raouf E. , McPhail, Andre, Pungpapong, Surakit , Crespo, Sergio, Keaveny, Andrew P. , Pungpapong, Surakit

Mayo Clinic

Clinical Transplantation | July 10, 2013 | Volume: 27 | Issue: 5 | Pages: 652-658

10.1111/ctr.12180 | PMID 23837611 Get It

AbstractBackgroundLiver biopsy has been the reference standard when evaluating fibrosis due to recurrent hepatitis after liver transplantation. Magnetic resonance elastography estimates liver stiffness, correlating to fibrosis.AimTo investigate the utility of elastography in staging liver fibrosis in transplant recipients with hepatitis C.MethodsFifty‐four patients, ≥12 months post‐transplant, underwent elastography within three months of biopsy. Discriminatory capability for METAVIR fibrosis stages F0–2 vs. F3–4 and receiver operating characteristic curve (ROC) analysis were determined.ResultsOn biopsy, 27 patients had METAVIR fibrosis score 0–1; 12 had a 3 or 4. There was significant correlation between histologic fibrosis and shear stiffness (R² = 0.588, p < 0.0001). Using a cutoff value of 3.5 kPa, elastography was 91% sensitive and 72% specific in differentiating fibrosis scores of ≥3 from 0 to 1. The AUC of elastography in predicting a fibrosis score of ≥3 was 0.92. Multivariate analysis revealed no correlation between the grade of histologic inflammation and liver stiffness measured by magnetic resonance elastography (R² = 0.265, p = 0.47).ConclusionMagnetic resonance elastography is an accurate non‐invasive technique for excluding stage ≥3 graft in recipients with hepatitis C.
Inositol 1,4,5-Trisphosphate Directs Ca2+Flow between Mitochondria and the Endoplasmic/Sarcoplasmic Reticulum: A Role in Regulating Cardiac Autonomic Ca2+Spiking
Jaconi, Marisa , Bony, Claire , Arnaudeau, Serge, Vassort, Guy, Pucéat, Michel , Richards, Stephen Michael , Terzic, André

Mayo Clinic

Molecular Biology of the Cell | July 2, 2013 | Volume: 11 | Issue: 5 | Pages: 1845-1858

10.1091/mbc.11.5.1845 | PMID 10793156 Get It

The signaling role of the Ca2+releaser inositol 1,4,5-trisphosphate (IP3) has been associated with diverse cell functions. Yet, the physiological significance of IP3in tissues that feature a ryanodine-sensitive sarcoplasmic reticulum has remained elusive. IP3generated by photolysis of caged IP3or by purinergic activation of phospholipase Cγ slowed down or abolished autonomic Ca2+spiking in neonatal rat cardiomyocytes. Microinjection of heparin, blocking dominant-negative fusion protein, or anti-phospholipase Cγ antibody prevented the IP3-mediated purinergic effect. IP3triggered a ryanodine- and caffeine-insensitive Ca2+release restricted to the perinuclear region. In cells loaded with Rhod2 or expressing a mitochondria-targeted cameleon and TMRM to monitor mitochondrial Ca2+and potential, IP3induced transient Ca2+loading and depolarization of the organelles. These mitochondrial changes were associated with Ca2+depletion of the sarcoplasmic reticulum and preceded the arrest of cellular Ca2+spiking. Thus, IP3acting within a restricted cellular region regulates the dynamic of calcium flow between mitochondria and the endoplasmic/sarcoplasmic reticulum. We have thus uncovered a novel role for IP3in excitable cells, the regulation of cardiac autonomic activity.